Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice.
about
Antineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicityCannabinoids and Epilepsy.Palmitoylethanolamide counteracts reactive astrogliosis induced by β-amyloid peptidePalmitoylethanolamide stimulation induces allopregnanolone synthesis in C6 Cells and primary astrocytes: involvement of peroxisome-proliferator activated receptor-α.Palmitoylethanolamide protects against the amyloid-β25-35-induced learning and memory impairment in mice, an experimental model of Alzheimer disease.'Entourage' effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolismMetabolite profiling in posttraumatic stress disorder.Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context.Palmitoylethanolamide inhibits glutamate release in rat cerebrocortical nerve terminalsPrimary fatty acid amide metabolism: conversion of fatty acids and an ethanolamine in N18TG2 and SCP cellsThe safety of cannabinoids for the treatment of multiple sclerosis.Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide.Microglia produce and hydrolyze palmitoylethanolamide.Identification of N-acylethanolamines in Dictyostelium discoideum and confirmation of their hydrolysis by fatty acid amide hydrolase.Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing-Remitting Multiple Sclerosis.Gap Junction Blockers: An Overview of their Effects on Induced Seizures in Animal Models.Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation.Fatty acid amide signaling molecules.Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator.Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain.Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.Palmitoylethanolamide Exerts Antiproliferative Effect and Downregulates VEGF Signaling in Caco-2 Human Colon Carcinoma Cell Line Through a Selective PPAR-α-Dependent Inhibition of Akt/mTOR Pathway.Palmitoylethanolamide is a disease-modifying agent in peripheral neuropathy: pain relief and neuroprotection share a PPAR-alpha-mediated mechanism.Delay of morphine tolerance by palmitoylethanolamide.Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 by macrophages and increases the resistance of mice against infections.Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systems.Selective effect of oleamide, an endogenous sleep-inducing lipid amide, on pentylenetetrazole-induced seizures in mice.HIV-1 Tat-induced diarrhea is improved by the PPARalpha agonist, palmitoylethanolamide, by suppressing the activation of enteric glia.Antiepileptogenic Effect of Subchronic Palmitoylethanolamide Treatment in a Mouse Model of Acute Epilepsy.Palmitoylethanolamide Ameliorates Hippocampal Damage and Behavioral Dysfunction After Perinatal Asphyxia in the Immature Rat Brain.Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect.Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer's Disease: In Vitro and In Vivo Evidence.N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.
P2860
Q27305830-5AFD09BA-B3D2-4277-A410-98B289000288Q27336451-936E024A-DFA5-4FAB-AD36-30D0EF2462F7Q28390536-5228D7C4-F5D8-45D6-A136-278D65F21245Q34183654-3A61A04D-0A1E-43D3-90EE-AE13BB0D688FQ34261073-60CA5E5F-1269-4E61-A6AB-2B30D7A452C3Q35044394-ED29E416-FC91-46CF-8ED0-E358292FD84EQ35200833-A73B0A0C-F19E-4642-93A0-EA60340E384DQ35222716-8CB593DF-7681-453A-A26C-16A8D5B97B3FQ35381177-11759D55-975D-42BA-ADFD-A35FF038A9B5Q35715609-1C33AFEB-992F-462E-A598-ED6359DF2F9EQ36150541-547A606F-05D7-40B0-924F-8F19CDD1DB36Q36348374-BD9593C0-4EAC-4BB9-8081-A437E866D050Q36477987-5372E79C-8DA9-4631-B699-C0D77711FBCCQ36658391-66ADBBF1-4744-4CCF-8DF9-470C91FB2920Q36775237-7A38C62B-909F-45CE-87AC-C499717B327BQ37310526-0A8A777E-4EED-4B2E-B8C6-AC9E73FAAA9DQ37469677-28EF18B6-3A54-4C7F-92AC-349399659EB7Q37785382-BD49A3AA-8C88-4D5A-945F-4A5D22E78562Q38118187-40918F17-C17D-4D60-A576-FE32CC6B6606Q38157791-8A122350-E160-44A1-B994-64CAC0DF302EQ38758364-C58497F8-C5BF-463E-A2B4-D96712EAE721Q38789993-7AB157AA-B508-4A6A-A020-9272DC72B689Q39230043-5AB5D03E-37EF-45B9-A330-C3FDCBF459DEQ41908176-6CEBA34D-9938-499A-83C5-FCE81029B421Q42719351-5E28C363-6639-45EF-8D9C-126B70E23C77Q44304365-EE24E010-A7D6-4A06-A7B8-A2322C6024F9Q44574234-FAD666E7-4667-43A0-B858-68DA06637ACBQ51735536-A6F9024B-0F01-41ED-8523-26A1768534CDQ52316988-42F7BB99-CC70-4040-B2EF-26B6425D72BDQ52584461-1753881D-91DC-4CF9-A608-FC34C35CF6CFQ52608759-FE8CFFE0-CEAC-4F0D-BA31-9D44CE29D215Q52632555-ACB1187B-BD62-4FD1-B3C0-A543739E9A64Q55094909-422D10A3-6504-4567-A736-5DB5CBC9B98C
P2860
Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice.
@ast
Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice.
@en
Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice.
@nl
type
label
Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice.
@ast
Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice.
@en
Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice.
@nl
prefLabel
Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice.
@ast
Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice.
@en
Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice.
@nl
P2093
P2860
P1433
P1476
Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice.
@en
P2093
Diependaele G
Govaerts SJ
Lambert DM
Vandevoorde S
P2860
P304
P356
10.1046/J.1528-1157.2001.41499.X
P577
2001-03-01T00:00:00Z